Studying the mechanism of Eps8-mediated cell survival in cisplatin-treated cancer cells

Studying the mechanism of Eps8-mediated cell survival in cisplatin-treated cancer cells

碩士 === 國立成功大學 === 藥理學研究所 === 99

Bibliographic Details
Main Authors:	I-ChinTu, 杜依靜
Other Authors:	Tzeng-Horng Leu
Format:	Others
Language:	zh-TW
Published:	2011
Online Access:	http://ndltd.ncl.edu.tw/handle/19639128867710382649

Similar Items

EPS8 inhibition increases cisplatin sensitivity in lung cancer cells.
by: Lidija K Gorsic, et al.
Published: (2013-01-01)

Correction: EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells
by: The Staff
Published: (2014-01-01)

Correction: EPS8 Inhibition Increases Cisplatin Sensitivity in Lung Cancer Cells.
Published: (2014-01-01)

Participation of Eps8 in v-Src mediated cell motility
by: Yi-Ting Yeh, et al.
Published: (2004)

Mechanisms of EPS8-mediated oncogenesis
by: Patel, Anisha Anilkumar
Published: (2007)

Wild-type p53 is required for Eps8-mediated chemoresistance in cancer cells
by: Wei-Han Cheng, et al.
Published: (2009)

Cisplatin and Paclitaxel Modulated the Cell Survival Potential of Prostate Cancer Cells
by: Sina Kashani, et al.
Published: (2020-01-01)

Participation of Eps8 in v-Ha-Ras mediated cell growth and transformation
by: Yen-Jen Chen, et al.
Published: (2005)

The Role of Eps8 in Ku70-mediated DNA Double Strand Break Repair in Cancer Cells
by: Chieh-ChunHsiao, et al.
Published: (2013)

Study the role of Eps8 in the interaction between cancer cells and macrophages
by: Wei-YingTseng, et al.
Published: (2017)

Participation of Eps8-Ku70 interaction in cancer cell proliferation
by: Chuan-LanHsu, et al.
Published: (2012)

The role of Eps8 in macrophage-stimulated colon cancer cell migration
by: Yu-ChenPan, et al.
Published: (2014)

Comparison of Oral Topotecan/Intravenous Cisplatin (TC) with Intravenous Etoposide/ Cisplatin (EP) as First Line Chemotherapy in Untreated Small Cell Lung Cancer Patient
by: Qiyi MENG, et al.
Published: (2009-02-01)

Participation of Eps8 in COX-2-mediated colorectal cancer formation
by: Meng-Shan Tsai, et al.
Published: (2006)

Mechanisms of resistance to cisplatin in ovarian cancer cells
by: Stephens, Imogen F. D.
Published: (1994)

Characterization of Cisplatin-Resistant Mechanism in Human Urothelial Carcinoma Cells
by: Ching-I Kuan, et al.
Published: (2007)

Reduced Eps8 expression by sodium butyrate treatment in colorectal cancer cells
by: Hsiu-Shan Yu, et al.
Published: (2002)

Reduced Eps8 expression by sodium butyrate treatment in colorectal cancer cells
by: Hsiu-Shan Yu, et al.
Published: (2002)

Functional study of the interaction between WWP2 and Eps8 in cancer cell
by: Tzu-JiunKuo, et al.
Published: (2015)

Cisplatin-induced hydroxyl radicals mediate pro-survival autophagy in human lung cancer H460 cells
by: Somruethai Sumkhemthong, et al.
Published: (2021-07-01)

Functional Study of Brk-mediated EPS8 Phosphorylation
by: Ching-Jung Lin, et al.
Published: (2010)

Studies of v-Src-mediated expression of Eps8
by: Ya-Cnun Chuang, et al.
Published: (2002)

Effect and Molecular Mechanism of MFG-E8 on Sensitivity of Ovarian Cancer SKOV3 Cells to Cisplatin
by: LI Na, et al.
Published: (2021-05-01)

Osteopontin isoform c promotes the survival of cisplatin-treated NSCLC cells involving NFATc2-mediated suppression on calcium-induced ROS levels
by: Jing Huang, et al.
Published: (2021-06-01)

Emergency Etoposide-Cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN)
by: Charleen Chan Wah Hak, et al.
Published: (2019-08-01)

Correction to: EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex
by: Nithya Subramanian, et al.
Published: (2020-11-01)

Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
by: Ding Q, et al.
Published: (2013-08-01)

The involvement of Eps8 phosphorylation in v-Src mediated transformation
by: Shu-YuHsu, et al.
Published: (2010)

Characterization of Ha-Ras-mediated eps8 gene expression
by: Shih-Yen Tseng, et al.
Published: (2008)

Study of Eps8 in EGFR-mediated mitogenesis and signal transduction
by: Tsai-Chien Cheng, et al.
Published: (2005)

Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines
by: Margaretha A. Skowron, et al.
Published: (2018-02-01)

Molecular cloning of eps8 gene from chicken embryonic cell
by: Tsung-Kun Chen, et al.
Published: (1999)

Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms
by: Ruchi P. Patel, et al.
Published: (2021-01-01)

EpCAM-positive disseminated cancer cells in bone marrow impact on survival of early-stage NSCLC patients
by: Bleicher, S., et al.
Published: (2022)

Insights into the Molecular Mechanisms of Phospholipase D-Mediated Cancer Cell Survival
by: Bruntz, Ronald Chase
Published: (2014)

Studies of v-Src-mediated p68EPS8 phosphorylation
by: Pi-Le Shih, et al.
Published: (2003)

The role of Eps8/Src axis in macrophage-mediated innate immunity
by: Ming-YuHsieh, et al.
Published: (2015)

Opposing effects of prostaglandin E2 receptors EP3 and EP4 on mouse and human β-cell survival and proliferation
by: Bethany A. Carboneau, et al.
Published: (2017-06-01)

Molecular mechanism of SPZ1 mediated cisplatin-resistance in human renal cell carcinoma
by: Bao-Wen Pan, et al.
Published: (2010)

Mechanism of Cisplatin-Induced Cytotoxicity and Cisplatin Resistance in Human Urothelial Carcinoma Cells
by: Yu, Hui-Min, et al.
Published: (2012)